prestige v

Prestige V

MRKVC210

Regular price
$28.95
Sale price
$28.95
Shipping calculated at checkout.

Prestige V is for vaccination of healthy horses, 6 months and older, as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis viruses and tetanus, as an aid in the control of respiratory disease caused by EIV, EHV-1 and EHV-4 and as an aid in reduction of virus shedding of EIV and EHV-1. Duration of immunity (DOI) has been shown to be at least six months for EIV.

Prestige V is for vaccination of healthy horses, 6 months and older, as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis viruses and tetanus, as an aid in the control of respiratory disease caused by EIV, EHV-1 and EHV-4 and as an aid in reduction of virus shedding of EIV and EHV-1. Duration of immunity (DOI) has been shown to be at least six months for EIV.

Advantages
  • Multiple antigen formulation reduces need for several injections
  • Formulated to minimize reactions and maximize protection
  • Available in 10-dose vials. Also available in convenient, low-volume 1 mL doses in single, prefilled syringes
  • Tetanus, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year
  • Provides six months of protection against EIV
  • A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains (EIV A/Equine 2/ Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03
  • Exceptional safety profile with the smooth Havlogen adjuvant
  • Advanced filtration process through the Antigen Purification System (APS™)
Administration and Dosage
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in three to four weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.